O
MR

OrbiMed’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

OrbiMed’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,000
Closed -$449K – 143
2013
Q2 		$449K Buy
+12,000
New +$474K 0.01% 125

Other funds holding MR

CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed's MR Position: Q3 2013 in Review

OrbiMed sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2013, closing a stake of 12,000 shares — an estimated $449K sold.

OrbiMed first reported a position in MR in Q2 2013 and held it in 1 quarter. The position peaked at $449K in Q2 2013. 165 funds tracked by Wall St. Rank hold MR as of Q3 2013.

  • OrbiMed reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2013 after selling out during the quarter.
  • OrbiMed sold 12,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2013, an estimated $449K.
  • OrbiMed first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 1 quarter.
  • OrbiMed's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $449K in Q2 2013.
  • 165 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2013.

Based on OrbiMed's 13F filing for Q3 2013, filed 14 Nov 2013.